Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Upcoming CMS Appropriate Use Criteria Policy For Ordering Advanced Imaging Raises Concerns

Executive Summary

Medical specialty groups are raising concerns about a planned policy change in 2020 by the US Medicare agency to require use of clinical decision support mechanism (CDSM) software to ensure physicians review appropriate use criteria before ordering advanced imaging scans.

You may also be interested in...



Medicare Changes For Medtech In 2020: What’s Ahead

The US Centers for Medicare and Medicaid Services (CMS) has finalized many new coverage policy decisions and coverage rules taking effect in 2020. Medtech Insight provides a review of what industry can expect this year from the Medicare agency.

CMS Proposes To Cover More Telehealth, And Address Imaging, Lab Pay Matters

The US Medicare agency has proposed several changes to the status quo in its planned 2019 Medicare physician fee schedule and clinical laboratory fee schedule that will impact reimbursements for telehealth services, the advanced imaging industry and clinical laboratories.

White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel